Insider Trading History of Omega Fund Iv, L.p.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Omega Fund Iv, L.p. since 2014. The trader's CIK number is 1528382. At the time of the last reporting, Omega Fund Iv, L.p. was the 10% Owner of Paratek Pharmaceuticals, Inc.. (stock ticker symbol PRTK). Also see all insider trading activities at Paratek Pharmaceuticals, Inc..

Note that in the past Omega Fund IV, L.P. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Paratek Pharmaceuticals, Inc. (PRTK) by Omega Fund Iv, L.p.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 PRTK 461,538 $5,999,994 0 $0 0 $0

Yearly summary of insider trading at Zyla Life Sciences (EGLT) by Omega Fund Iv, L.p.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 EGLT 239,583 $2,874,996 0 $0 0 $0


Insider trading activities at 2 companies by Omega Fund Iv, L.p.:

1. Paratek Pharmaceuticals, Inc. (PRTK)

2. Zyla Life Sciences (EGLT)

Table 1. Insider trading of Paratek Pharmaceuticals, Inc. (PRTK) by Omega Fund Iv, L.p.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-06-27 PRTK Buy 461,538 13.00 5,999,994

Table 2. Insider trading of Zyla Life Sciences (EGLT) by Omega Fund Iv, L.p.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-02-11 EGLT Buy 239,583 12.00 2,874,996

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Omega Fund Iv, L.p. (10% Owner of Paratek Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.